AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Revenue growth (%)

KAKEN PHARMACEUTIAL CO., LTD.【JP:4521】

Market cap
¥198.9B
P/E ratio
71.3x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 202530.5-2465.89%
Mar 31, 2024-1.3-67.83%
Mar 31, 2023-4-384.40%
Mar 31, 20221.4-108.83%
Mar 31, 2021-16+204.77%
Mar 31, 2020-5.2+21.02%
Mar 31, 2019-4.3+44.33%
Mar 31, 2018-3-60.11%
Mar 31, 2017-7.5-144.58%
Mar 31, 201616.9+203.42%
Mar 31, 20155.6+156.22%
Mar 31, 20142.2-302.80%
Mar 31, 2013-1.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)